Tokyo Tape
Sign in
← Ono Pharmaceutical

Quarterly report · Q3

4528.TEDINET S100SO43
Period2023-04-01 → 2023-12-31
Filed2024-02-06
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥389.9bn2023-04-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥131.2bn2023-10-01 → 2023-12-31dCons.Revenue IFRS
Revenue¥447.2bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥339.0bn2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥122.3bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Operating income¥144.6bn2023-04-01 → 2023-12-31Cons.Operating profit loss IFRS
Operating income¥47.6bn2023-10-01 → 2023-12-31dCons.Operating profit loss IFRS
Operating income¥122.6bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥42.3bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Profit before tax¥147.3bn2023-04-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥48.0bn2023-10-01 → 2023-12-31dCons.Profit loss before tax IFRS
Profit before tax¥143.5bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥124.4bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥43.4bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥110.5bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥36.1bn2023-10-01 → 2023-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥112.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥95.7bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥33.3bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥110.6bn2023-04-01 → 2023-12-31Cons.Profit loss IFRS
Net income¥36.1bn2023-10-01 → 2023-12-31dCons.Profit loss IFRS
Net income¥95.8bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥33.4bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Total assets¥891.7bnat 2023-12-31Cons.Assets IFRS
Total assets¥882.4bnat 2023-03-31Cons.Assets IFRS
Total assets¥830.5bnat 2022-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥101.0bnat 2023-12-31Cons.Liabilities IFRS
Total liabilities¥134.6bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥790.7bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥747.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥727.3bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥661.7bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥784.7bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥741.9bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥721.4bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥102.2bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥96.1bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥108.6bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥69.1bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥61.5bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥159.6bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥115.1bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥19.4bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥100.3bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥44.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥75.4bn2023-04-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥32.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥30.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥229.082023-04-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥75.772023-10-01 → 2023-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥230.852022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥195.92022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥68.232022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥229.062023-04-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥75.762023-10-01 → 2023-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥230.792022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥195.882022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥68.222022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio88.0%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio84.1%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio86.9%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 573
ItemContextValueUnit
Equity IFRSCurrentQuarterInstant790680000000JPY
Liabilities and equity IFRSPrior1YearInstant882437000000JPY
Liabilities and equity IFRSCurrentQuarterInstant891725000000JPY
Revenue IFRSPrior1YTDDuration339020000000JPY
Revenue IFRSCurrentYTDDuration389903000000JPY
Cost of sales IFRSPrior1YTDDuration83787000000JPY
Cost of sales IFRSCurrentYTDDuration95462000000JPY
Gross profit IFRSPrior1YTDDuration255233000000JPY
Gross profit IFRSCurrentYTDDuration294441000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration66147000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration73295000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration65974000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration76493000000JPY
Other income IFRSPrior1YTDDuration518000000JPY
Other income IFRSCurrentYTDDuration979000000JPY
Other expenses IFRSPrior1YTDDuration1041000000JPY
Other expenses IFRSCurrentYTDDuration1007000000JPY
Operating profit loss IFRSPrior1YTDDuration122590000000JPY
Operating profit loss IFRSCurrentYTDDuration144626000000JPY
Finance income IFRSPrior1YTDDuration2409000000JPY
Finance income IFRSCurrentYTDDuration3120000000JPY
Finance costs IFRSPrior1YTDDuration624000000JPY
Finance costs IFRSCurrentYTDDuration458000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration4000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration4000000JPY
Profit loss before tax IFRSPrior1YTDDuration124379000000JPY
Profit loss before tax IFRSCurrentYTDDuration147292000000JPY
Income tax expense IFRSPrior1YTDDuration28551000000JPY
Income tax expense IFRSCurrentYTDDuration36682000000JPY
Profit loss IFRSPrior1YTDDuration95827000000JPY
Profit loss IFRSCurrentYTDDuration110610000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration95656000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration110544000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration172000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration66000000JPY
Profit loss IFRSPrior1YTDDuration95827000000JPY
Profit loss IFRSCurrentYTDDuration110610000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration195.90
Basic earnings loss per share IFRSCurrentYTDDuration229.08
Diluted earnings loss per share IFRSPrior1YTDDuration195.88
Diluted earnings loss per share IFRSCurrentYTDDuration229.06
Revenue IFRSPrior1QuarterDuration122319000000JPY
Revenue IFRSCurrentQuarterDuration131191000000JPY
Cost of sales IFRSPrior1QuarterDuration30075000000JPY
Cost of sales IFRSCurrentQuarterDuration30697000000JPY
Gross profit IFRSPrior1QuarterDuration92244000000JPY
Gross profit IFRSCurrentQuarterDuration100493000000JPY
Selling general and administrative expenses IFRSPrior1QuarterDuration23202000000JPY
Selling general and administrative expenses IFRSCurrentQuarterDuration25691000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1QuarterDuration26346000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-10-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2023-10-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass